Literature DB >> 24942005

Acyclovir-Induced Neurotoxicity: A Case Report and Review of Literature.

Mohammed Andaleeb Chowdhury1, Nada Derar, Syed Hasan, Bryan Hinch, Shoba Ratnam, Ragheb Assaly.   

Abstract

Neurotoxicity can develop as a side effect of intravenous acyclovir use in patients with renal impairment. It is underreported in clinical practice and often confused with worsening herpes encephalitis. We present a 69-year-old woman with end-stage renal disease on hemodialysis with acyclovir neurotoxicity treated with daily extended hemodialysis sessions. Daily hemodialysis for extended period may shorten the neurotoxicity period and can help with faster return to normal mentation. A high index of suspicion is warranted to diagnose acyclovir-induced neurotoxicity.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 24942005     DOI： 10.1097/MJT.0000000000000093

Source DB:  PubMed          Journal:  Am J Ther        ISSN： 1075-2765            Impact factor:   2.688


  8 in total

1.  Comparison of three cell-based drug screening platforms for HSV-1 infection.

Authors:  Leonardo D'Aiuto; Kelly Williamson; Peter Dimitrion; James McNulty; Carla E Brown; Chanti Babu Dokuburra; Alexander J Nielsen; Wen Jing Lin; Paolo Piazza; Mark E Schurdak; Joel Wood; Robert H Yolken; Paul R Kinchington; David C Bloom; Vishwajit L Nimgaonkar
Journal:  Antiviral Res       Date:  2017-03-23       Impact factor: 5.970

2.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

3.  Herpetic encephalitis: which treatment for which body weight?

Authors:  Marine Mulatero; Mohamed Boucekine; Olivier Felician; Salah Boussen; Gilles Kaplanski; Pascal Rossi; Philippe Parola; Andréas Stein; Philippe Brouqui; Jean Christophe Lagier; Marc Leone; Elsa Kaphan
Journal:  J Neurol       Date:  2022-01-31       Impact factor: 4.849

4.  Concurrent Nephrotoxicity and Neurotoxicity Induced by Oral Valacyclovir in a Patient With Previously Normal Kidney Function.

Authors:  Ziad Abuhelwa; Azizullah Beran; Barat S Venkataramany; Bryan T Hinch; Ragheb Assaly
Journal:  Cureus       Date:  2022-03-31

5.  R430: A potent inhibitor of DNA and RNA viruses.

Authors:  Leonardo D'Aiuto; James McNulty; Caroll Hartline; Matthew Demers; Raj Kalkeri; Joel Wood; Lora McClain; Ansuman Chattopadhyay; Yun Zhi; Jennifer Naciri; Adam Smith; Robert Yolken; Kodavali Chowdari; Carlos Zepeda-Velazquez; Chanti Babu Dokuburra; Ernesto Marques; Roger Ptak; Paul Kinchington; Simon Watkins; Mark Prichard; David Bloom; Vishwajit Nimgaonkar
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

Review 6.  Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.

Authors:  Mohd H Abdul-Aziz; Jan-Willem C Alffenaar; Matteo Bassetti; Hendrik Bracht; George Dimopoulos; Deborah Marriott; Michael N Neely; Jose-Artur Paiva; Federico Pea; Fredrik Sjovall; Jean F Timsit; Andrew A Udy; Sebastian G Wicha; Markus Zeitlinger; Jan J De Waele; Jason A Roberts
Journal:  Intensive Care Med       Date:  2020-05-07       Impact factor: 17.440

7.  Encephalopathy Induced by Preventive Administration of Acyclovir in a Man with Symptomatic Multiple Myeloma and Renal Dysfunction.

Authors:  Kazuma Sugimoto; Tsuneaki Kenzaka; Ryu Sugimoto; Akihito Kitao; Hozuka Akita
Journal:  Int J Gen Med       Date:  2021-02-11

Review 8.  Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: A case report and literature review.

Authors:  Tsuneaki Kenzaka; Kazuma Sugimoto; Ken Goda; Hozuka Akita
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.